Navigation Links
Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
Date:10/28/2008

New Survey Quantifies Misperceptions about Liver Cancer in the United

States

WAYNE, N.J. and EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- A new survey of more than 1,000 American adults revealed that general knowledge regarding liver cancer risk factors and treatment options is limited, even among individuals with a connection to the disease. According to the GfK Roper survey, among those aware of the disease approximately 60 percent are unable to name a single symptom associated with liver cancer and more than 40 percent are unaware of treatment options.

To address this lack of knowledge and awareness of liver cancer in the United States, Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX), in partnership with leading advocacy organizations the American Liver Foundation (ALF) and Vital Options International, today announced the launch of Living with Liver Cancer -- a program designed to educate patients and caregivers about liver cancer signs and symptoms, risk factors, diagnosis, screening and available treatment options.

The centerpiece of the program is the Living with Liver Cancer Web site (http://www.LivingwithLiverCancer.com), which serves as a resource for people seeking more information about liver cancer and liver disease. To expand access and availability of the program to a wider audience, information on the Web site will be translated into several different languages, including Chinese and Spanish. More than 600,000 cases of liver cancer are diagnosed worldwide each year, including 15,000 cases in the United States.(1,2)

"There is a need for greater understa
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Bayer Diabetes Care Partners with Nick Jonas to Encourage Young People to Proactively Manage Their Diabetes
2. Photos: Bayer Names New U.S. CEO
3. Bayer USA Foundation Supports Summer Science Education Programs in Pittsburgh, Raleigh, Houston and Tyler, Texas
4. Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
5. Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution
6. Bayer Announces Availability of Reformulated Liquid Leukine(R)
7. ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
8. United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition
9. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
10. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
11. Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Mass., (PRWEB) September 01, 2014 BCC ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , ... $21.8 million in 2013 and is expected to reach ... grow to $471.5 million by 2019, which is equivalent ... through 2019. The receptor-mediated transport (RMT) segment is forecasted ...
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ... status conference in September, where issues related to claims ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... on the Court’s website, the meeting is scheduled to ... This is the latest of several Tylenol conferences that ...
(Date:9/1/2014)... Ontraport , one of the latest ... to automate the small intricacies of managing an online ... prompting an investigative review. , “As a new ... all of the small details involved with running a ... “That’s why Ontraport has become so popular in this ...
(Date:9/1/2014)... Diego, CA (PRWEB) September 01, 2014 ... daily regarding all the latest information from the FDA ... , The US FDA announced on August 28, that ... recalled (Class I) as the device may ... the DePuy Synthes Craniomaxillofacial (CMF) Distraction System is an ...
(Date:9/1/2014)... 01, 2014 Beginning Tuesday, September 2nd, ... medical professionals and 10,000 consumers for the annual gathering ... gathering of the nation’s top medical professionals who specializes ... conditions. The week-long event contains more than 120 hours ... available in the pain management field. , MarijuanaDoctors.com is ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2
... presented today,at the Society of Interventional Radiology,s 33rd ... Atlanta metro area, only 18 percent of the,women ... about uterine,fibroid embolization (UFE), a minimally invasive treatment ... a safe, effective,established treatment that has been widely ...
... N.C., March 18 The key to collecting,meaningful ... data. Companies use tools and techniques ranging in ... competitor, to monitoring the air,emissions outside a Competitor,s ... methods and often experiment with new collection,sources to ...
... walking problems , , TUESDAY, March 18 (HealthDay News) -- The ... affects how well older people are able to move around ... matter changes -- called leukoaraiosis -- are common in older ... ages 65 to 84, who underwent walking and balance tests, ...
... Corporation,(Nasdaq: SMTS ) reported net revenues of $8.7 ... 8 percent increase from $8.0 million in the,same period ... to $7.4 million from $6.6,million in the same period ... $1.4 million last year., First quarter income before ...
... March 18 Cardinal Health, a,global provider of products ... care, today announced the appointment of former,Acting Deputy U.S. ... officer, a newly expanded position., Morford, 49, has ... in,public service with the Department of Justice, including serving ...
... Management,Services, Inc. (Nasdaq: BDMS ), operators ... the year ended December 31, 2007. Total,dental ... 3.9%, to $59.4,million. Net revenue increased $1.4 ... earnings before interest, taxes, depreciation, amortization and,non-cash ...
Cached Medicine News:Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 2Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 3Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 4Health News:Balance in Old Age Tied to Brain Changes 2Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 2Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 3Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 4Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 5Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 6Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 7Health News:Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post 2Health News:Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post 3Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 2Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 3Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 4Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 5Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 6Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 7Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 8
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... The report firstly reviews the basic information of ... manufacturing technology. The report then explores global and ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... FRANKLIN LAKES, N.J. , May 11 ... agonists (LABAs) alone, and not in combination with other ... Food and Drug Administration (FDA) on the risk of ...  This according to a new study from the ...
... , May 11 The DNA Medicine Institute announced today ... from the Bill & Melinda Gates Foundation.  The grant will support an ... M.D. titled "Optomagnetic Finger Scanner for Malaria." , ... Dr. Chan,s project is one of 78 grants announced ...
Cached Medicine Technology:Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 2Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 3Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 4Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 5DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: